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Abstract
Background: The diagnostic value of NT-proBNP for left ventricular (LV) systolic dysfunc-
tion is well established. However, its role for diastolic dysfunction (DD) diagnosis in patients
with preserved systolic function has not been clearly defined.
Methods: A total of 83 patients with documented coronary arterial disease following anterior
myocardial infarction and with a left ventricular ejection fraction (LVEF) > 45% were
enrolled. According to echocardiographic mitral inflow and right upper pulmonary vein flow,
DD was excluded in 32 patients (group A). The patients with DD were divided into three
subgroups: B1 — 38 patients with impaired relaxation, B2 — 8 patients with
pseudonormalisation and B3 — 7 patients with restrictive inflow. In all patients E-wave
propagation (Vp) and NT-proBNP were determined.
Results: Mean LVEF was 56.2 ± 9% and did not differ between the subgroups. NT-proBNP
levels were 107 ± 101 pg/ml in group A, 299 ± 281 pg/ml in B1, 734 ± 586 pg/ml in B2
(p < 0.05 vs. A) and 2322 ± 886 pg/ml in B3 (p < 0.01 vs. A and p < 0.01 vs. B2).
Propagation Vp was 69 ± 21 cm/s, 56 ± 20 cm/s, 53 ± 17 cm/s (p < 0.05 vs. A) and 44 ± 11 cm/s
(p < 0.01 vs. A) respectively. A positive correlation was found for DD degree with NT-proBNP
level (r = 0.66; p < 0.001) and negative with Vp (r = –0.41; p < 0.001). ROC curves were
constructed to determine the NT-proBNP level cut-off point for DD (> 131 pg/ml, area under
the curve: 0.63) and advanced restrictive DD (> 1670 pg/ml, area under the curve: 0.83)
diagnosis. Sensitivity, specificity, accuracy and positive and negative predictive values were
71%, 50%, 63%, 69%, 52% and 57%, 99%, 95%, 80%, 96% respectively.
Conclusions: In patients with coronary artery disease and preserved LV systolic function
a single NT-proBNP measurement helps to identify those with isolated DD, especially those with
advanced restriction. (Folia Cardiol. 2006; 13: 620–625)
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Introduction
Diastolic left ventricular (LV) dysfunction is
present in over 35% of patients with heart failure symp-
toms [1, 2]. Diastolic heart failure (DHF) is especially
common in the elderly and individuals with concomi-
tant hypertension, diabetes or aortic stenosis. It is more
frequent in females. Isolated DHF diagnosis is, accord-
ing to the ESC Task Force, based on heart failure
symptoms in the presence of normal or mildly de-
creased left ventricular ejection fraction (LVEF
≥ 45–50%) and evidence of abnormal relaxation or
LV diastolic stiffness [3]. Currently there are no eas-
ily implemented and precise criteria for relaxation dis-
turbance or wall stiffness assessment. The method
of choice in DHF diagnosis is echocardiography with
mitral inflow indices, right upper pulmonary vein flow
and mitral annulus movement using spectral, colour-
coded or tissue Doppler. The limitations of these tech-
niques arise from coexisting atrial fibrillation, frequent
ventricular and supraventricular ectopy or other clin-
ical parameters such as age, LV filling pressure, heart
rate and underlying heart disease [4].
The increase in the number of patients with
coronary artery disease and diastolic dysfunction
(DD) has made it imperative that research be con-
ducted for new simple methods of diagnosis [5, 6].
Impaired LV filling pressure, the main factor
contributing to DD, causes heart neurohormone
release. The key role is held by brain natriuretic
peptide (BNP) synthesised in the ventricular my-
ocardium. Recently published data has revealed the
high diagnostic value of BNP and its biologically ac-
tive part N-terminal proBNP (NT-proBNP) in systo-
lic heart failure [7–9]. The role of these peptides in
DD diagnosis has recently been investigated [10, 11]
and significant correlations with the degree of DD
have been found in patients with low LVEF [12].
Understanding of NT-proBNP behaviour in isola-
ted left ventricular DD is, however, limited.
The aim of the study was to assess the useful-
ness of NT-proBNP in the diagnosis of isolated LV
diastolic dysfunction in patients with documented
coronary disease and preserved LV systolic func-
tion with different patterns of mitral flow abnormal-
ity in Doppler echocardiography. Secondly, we tried
to compare two DD indices, namely NT-proBNP
and E-wave propagation, for identification of a pseu-
donormal mitral inflow pattern
Methods
Eighty-three consecutive patients (54 males of
mean age 56.4 ± 10 years), who had had a docu-
mented anterior wall myocardial infarction at least
6 months earlier, had been treated with early per-
cutaneous coronary intervention and had a current
LVEF > 45%, were enrolled [4]. Significant coro-
nary lesions were defined as left main stenosis
> 50% and > 70% in the other coronaries.
Echocardiography was performed in typical
apical views with a VIVID 7 (GE Vingmed, Norway)
machine. Systolic and diastolic LV volumes were
calculated according to the Simpson method. LVEF
was calculated as a percentage of the difference in
systolic and diastolic volume.
A spectral pulse-wave Doppler probe was
placed in four-chamber apical view at the apex of
the mitral valve cusps for mitral inflow assessment
including maximal velocity of early inflow (E wave),
maximal velocity of atrial flow (A wave) and decel-
eration time of early flow (DT). Next, the probe was
placed in the right upper pulmonary vein (RUPV)
at a point 1–2 cm from its opening to the left atrium
for flow assessment (Fig. 1). This parameter was
used to differentiate normal and pseudonormal mi-
tral inflow [1] on the basis of the assumption that
higher diastolic left atrial pressure correlates with
maximal RUPV flow velocity during systole (S),
diastole (D) and atrial contraction (Ar).
The widely recognised index of LV diastolic
dysfunction, that of E-wave propagation (Vp), was
assessed in a four-chamber view with colour-cod-
ed M-mode. After optimalisation of the area of in-
terest at Nyquist limit the velocity of the inflow
wave was registered at the segment from mitral
annulus to 4 cm in the apical direction. The propa-
gation was calculated as the slope of a line parallel
to the red and blue border in M-mode.
Figure 1. Normal pulmonic vein flow in right upper pul-
monary vein (pulse wave Doppler); S-wave — systolic
forward flow, D-wave — diastolic forward flow,
Ar — atrial reversed flow, ZPGP — right upper pulmo-
nary vein
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On the basis of mitral and RUPV indices, as put
forward by Madinov et al. [5] and Appleton et al. [13],
patients were divided into four subgroups. Group A
had normal diastolic function, while the other three
groups had DD, group B1 impaired relaxation, group
B2 pseudonormalisation and group B3 restrictive in-
flow. Abnormal relaxation was recognised when the
E/A ratio was < 1.0 and DT > 220 ms, pseudonor-
mal patterns when the E/A ratio was 1–2, DT 150–
–220 ms, S/D < 1 and Ar > 35 cm/s. and restriction
when the E/A ratio was < 1 and DT < 150 ms.
In all patients, shortly after echocardiographic
examination, blood was drawn for NT-proBNP as-
sessment with chemiluminescent immunoassay kit
(Roche Diagnostics) on an Elecsys 2010 analyser.
Statistics analysis
Data are presented as means and standard de-
viations, or absolute numbers and percentages
where appropriate. Distribution was checked with
the Kolmogorow-Smirnow, Lilliefors and Shapiro-
-Wilks-W tests. Comparisons between means were
performed with Student’s t-test or Mann-Whitney-U
and Kolmogorow-Smirnow tests. For qualitative
data c2 with Yates’ correction was used. Linear re-
gression and Spearman’s correlation coefficient
were determined. Parameters which differed sig-
nificantly between one group and the next were
used to construct a logistic regression model with
quasi-Newton estimation.
Sensitivity, specificity, predictive values and
accuracy were determined for NT-proBNP dichoto-
mising values from the ROC curves to diagnose any
DD and advanced DD.
Results
The characteristics of the 83 enrolled patients
are presented in Table 1. A significant negative
correlation was found for E-wave propagation ve-
locity and NT-proBNP (r = –0.44 p < 0.00005).
A significant positive correlation was between
the patient’s age and NT-proBNP (r = 0.66,
p < 0.000009).
According to mitral inflow and right upper pul-
monary vein flow, two groups were distinguished:
Table 1. Characteristics of patients.
Number 83
Age (years) 59.6 ± 10
Male 69.9%






Propagation velocity [cm/s] 60 ± 21
E-wave [cm/s] 76.1 ± 18.5
A-wave [cm/s] 74.1 ± 24.0
E/A 1.19 ± 0.69
E-wave deceleration time [ms] 244.9 ± 84.8
Left ventricular end-diastolic 104.5 ± 33.7
volume [ml]
Left ventricular end-systolic 47.8 ± 22.4
volume [ml]
Left ventricular ejection fraction 56.1 ± 8.1%
NT-proBNP [ng/ml] 461.1 ± 918.9
E-wave — early mitral inflow peak velocity, A-wave — atrial mitral inflow
peak velocity, E/A — ratio of early to atrial mitral inflow peak velocity
Table 2. Value of NT-proBNP propagation in patients with isolated diastolic dysfunction.
Group A Group B Group B1 Group B2 Group B3
Propagation [cm/s] 69±20 54±19 56±20 54±17 44±11
NT-proBNP [pg/ml] 107±101 645±135 299±281 734±586 2322±886
group A — 32 patients with normal flow and group
B — 51 patients with impaired flow. Depending on the
degree of LV DD, group B was divided into three sub-
groups: B1 — 36 patients with relaxation mitral flow,
B2 — 8 patients with a pseudonormalisation pattern and
group B3 — 7 patients with a restrictive profile.
These subgroups did not differ in age or LVEF,
although groups A and B1 tended to have a higher
ejection fraction. Mean Vp in group A was higher
than in group B (p < 0.02) (Table 2) and decreased
in consecutive subgroups B1–3 in keeping with DD
severity. Significant differences were found for Vp
in group A in comparison with subgroup B2
(p < 0.006) and B3 (p < 0.003).
Mean NT-proBNP was significantly higher in
group B (p < 0.05) (Table 2). NT-proBNP increased
with increasing DD severity: in group B1 — 299 ±
± 281 pg/ml (p < 0.05 vs. A), in group B2 — 734 ±
± 586 pg/ml (p < 0.01 vs. A) and in group B3 — 2322 ±
± 886 pg/ml (p < 0.006 vs. B2, p < 0.002 vs. A).
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For the whole population studied a significant positive
correlation was found between NT-proBNP and
degree of DD (r = 0.66, p < 0.006).
According to ROC analysis the best discriminat-
ing factor for DD diagnosis was NT-proBNP value
> 131 pg/ml and the best value for the restrictive
form of DD was NT-proBNP > 1670 pg/ml. The ar-
eas under the ROC curve for these two discriminating
values were 0.63 and 0.83 respectively (Fig. 2). Sensi-
tivity, specificity, accuracy and positive and negative
predictive values were 71%, 50%, 63%, 69%, 52%
and 57%, 99%, 95%, 80%, 96% respectively.
Separate analysis was performed of patients
with normal mitral inflow in whom a pseudonormal
profile could be diagnosed on the basis of NT-proBNP
> 332 pg/ml with 85% accuracy, 62.5% sensitivity
and 97% specificity. Accordingly, an E-wave prop-
agation velocity of E < 53 cm/s distinguished pa-
tients with mild dysfunction with 66% accuracy,
78% sensitivity and 59% specificity. The area un-
der the ROC curve for NT-proBNP was larger than
for E-wave velocity (0.83 vs. 0.63).
The logistic regression analysis incorporated
parameters significantly related to DD: demographic
and coronary disease risk factors and NT-proBNP
revealed that only NT-proBNP and body mass in-
dex were independent predictors of DD with an
odds ratio of 1.28 (CI 95% 1.16–1.42) for every unit
NT-proB-NP level increase.
Discussion
Doppler echocardiography is the most fre-
quently used method for diastolic function assess-
ment with mitral inflow parameters with a high cor-
relation with haemodynamic studies [14, 15]. How-
ever it has limited value in differentiating normal
inflow from the pseudonormal, representing the
sum of left atrial pressure increase and relaxation
disturbances [16]. Additional RUPV flow analysis
helps to differentiate these two profiles [17, 18].
Unfortunately high quality measurements and pre-
cise interpretation require of the examiner long
experience and deep knowledge, especially of the
factors influencing the parameters under assess-
ment, including LV afterload, heart rate, respirato-
ry phase, LV filling pressure, ejection fraction, phar-
macotherapy and patient age [4, 19, 20].
Natriuretic peptides are released into the
blood in response to increased wall tension, main-
ly of the left ventricle. Some recent publications
have therefore suggested that higher levels of
natriuretic peptides, especially NT-proBNP, could
become a marker of isolated DD [21, 22]. Howev-
er, the populations studied are small and have con-
sisted of patients with various DD aetiologies. The
results of our study confirm the high value of sin-
gle NT-proBNP assessment in patients with cor-
onary artery disease for isolated DD diagnosis.
Tschope et al. [1] have, in a recent paper, revealed
a similar sensitivity of 69% for DD recognition.
Despite the very similar cut-off value for NT-proB-
NP (120 pg/ml), we obtained significantly lower
values for DD exclusion. The differences are prob-
ably due to characteristics of the population stud-
ied, that in the Tschope study having only 34% of
patients with confirmed coronary disease. The lev-
el of natriuretic peptides was found to be increased
in patients with coronary artery disease [23]. Our
study population was also older with presumed
higher levels of NT-proBNP.
The very high NT-proBNP levels in patients
with a restrictive mitral inflow pattern were signifi-
cantly different from those in the other subgroups.
The mean value of 2322 pg/ml in these patients is
similar to that described by Tschope et al. [1], who
for left ventricular DD used both echocardiograph-
ic and direct pressure measurements. The high
specificity and very high (96%) negative predictive
value helps to exclude advanced isolated LV DD
with NT-proBNP assessment. This has been con-
firmed by others [24]. NT-proBNP measurement is
also useful in differentiating normal mitral flow from
Figure 2. ROC curves of NT-proBNP for distinguishing
early diastolic dysfunction and advanced diastolic dys-







Isolated diastolic dysfunction — AUC = 0.63
Restriction — AUC = 0.83
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a pseudonormal pattern, a scenario which is diffi-
cult in baseline Doppler echocardiography indices
analysis. NT-proBNP level is better then early mi-
tral flow propagation, which, despite a high negative
correlation with invasive measurements in experi-
mental and clinical studies, is dependent on the pa-
tient’s age, heart rate and LVEF. The E-wave prop-
agation velocity cut-off point (53 cm/s) is higher then
that recommended by other studies (45 cm/s), prob-
ably because of the relatively high LVEF [18].
Logistic regression analysis revealed that only
NT-proBNP and body mass index were independ-
ent predictors for DD diagnosis, with an odds ratio
of 1.28 for every unit of NT-proBNP growth. The
influence of obesity on heart failure progression is
well known [25], although obese patients have low-
er levels of natriuretic peptides because of higher
BNP clearance, with higher fat cell endopetidase
activation leading to faster BNP degradation, or
decreased myocardial synthesis [26, 27].
Limitations
The number of patients in more advanced LV
DD is relatively small. The study lacks invasive
pressure and volume measurements, the gold
standard for DD assessment.
Conclusions
In patients with coronary heart disease and
preserved LV systolic function a single NT-proBNP
measurement helps to identify patients with iso-
lated DD, especially those in the most advanced
restrictive phase. NT-proBNP better differenti-
ates patients with pseudonormal mitral flow pro-
file than does the proposed E-wave propagation
assessment.
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